R2M Pharma, Inc.
Medicinal chemistry partner for small-molecule drug discovery and preclinical development.
R2M Pharma is a medicinal chemistry CRO specializing in small-molecule drug discovery and preclinical development, from hit validation through GLP toxicology studies. Headquartered in South San Francisco, United States.
Phases
Services
Modalities
Technical specifications & accreditations
Accreditations
About this organization
R2M Pharma partners with biotech and research organizations on small-molecule drug discovery projects. The company provides medicinal chemistry expertise across all stages of discovery and preclinical development, including hit validation and GLP toxicology studies. R2M emphasizes close collaboration with client biology, DMPK, and CMC teams, and offers strategic support on intellectual property strategy.
Locations
Headquarters
South San Francisco · CA · USA
Related companies
Similar profiles by shared services, phases, and indications.
AAPharmaSyn- Medicinal Chemistry
- Discovery Research
Synfini, Inc.- Medicinal Chemistry
- Discovery Research
CanAm Bioresearch Inc.- Medicinal Chemistry
- Discovery Research
PozeSCAF Inc.- Medicinal Chemistry
- Discovery Research
- Aurigene Pharmaceutical Services Limited
- Medicinal Chemistry
- Discovery Research
Eurofins Discovery- Medicinal Chemistry
- Discovery Research
Vipergen- Discovery Research
- Small Molecule
BioQual Solutions Inc.- GLP Toxicology
- Small Molecule
Submit a verified review for this organization.
Markdown mirror: /companies/r2mpharma.md